Thursday May 18, 2006 17:00 - 19:00 Registration Friday May 19, 2006 from 07:30 Registration Welcome Address 08:30 - 10:45 SESSION I Chair: Sophie Mavrogeni (Athens, Greece) Guillem Pons-Llado (Barcelona, Spain) 1: Anatomy and right planning 2: How to find the right Pulse sequences 3: Fast Imaging
Sebastian Kozerke (Zürich, Switzerland)
4: Dealing with Artifacts
Albert van Rossum (Amsterdam, The Netherlands)
5: Evaluation of Function and Volumes 6: Flow-Measurements
Sebastian Globits (St. Pölten, Austria)
7: Tagging 8: Contrast agents 10:30 - 11:15 Coffee break
11:15 - 12:50 SESSION II Assessment of CAD- Perfusion and Viability Chair: Sebastian Globits (St. Pölten, Austria) Dudley Penell (London, UK) 9: Perfusion MR Imaging 10: Late-enhancement for myocardial viability 11: Dobutamine stress for myocardial viability 12: Case presentation 1 13: Case presentation 2 14: Case presentation 3
12:30 - 12:51 Oral Abstract Presentation 15: Combined Coronary Artery Imaging, Myocardial Perfusion and Delayed Enhancement in Patients with Suspected Coronary Artery Disease.
C. Klein; T. Kokocinski; R. Gebker; B.Schnackenburg; E. Fleck; E. Nagel. German Heart Institute Berlin, Philips Medical Systems, Berlin, Germany 16: Risk stratification after reperfused acute myocardial infarction using delayed contrast-enhanced cardiovascular magnetic resonance. M. Regenfus, C. Stingl, C. Schlundt, J. von Erffa, M. Schmidt, W. Adler, W. G. Daniel. Medical Clinic II and Institut of Biometry, FAU Erlangen- Nürnberg, Siemens Medical Solutions, Erlangen, Germany 17: Prognostic value of a negative adenosine stress perfusion CMR in patients with suspected coronary artery disease. G. von der Recke, D. Hardung, K. Miszalski-Jamka, B. Saxler, Jan Schnapauff, H. Omran. St.-Marien-Hospital, Bonn, Germany 12:51 - 14:15 Lunch (Klimt Room)
12:51 - 14:15 Nucleus Meeting (Berg Room)
14:15 - 15:50 SESSION III Assessment of CAD – The clinical approach Chair: Udo Sechtem (Stuttgart, Germany) Frank Rademakers (Leuven, Belgium) 18: Perfusion/Viabitity is more important than luminography 19: Luminography is equivalent to Perfusion/Viability 14:45 -15:00 20: The radiation issue 21: MSCT vs. MRI Panel discussion
15:45 - 16:45 Coffee break and Poster Presentation I (16:00 – 16:40) 16:00 - 16:40 Poster Session I / I Chair: Katharina Kiss (Vienna, Austria) 16:00 -16:05 P1: Coronary Artery And Viability Evaluation In Polyarteritis Nodosa, Microscopic Polyangiitis And Wegener Granulomatosis Using MRI
S Mavrogeni, TC Karagiorga, MN Manoussakis,
M Douskou, HM Moutsopoulos, DV Cokkinos. Onassis Cardiac
Surgery Center, Dept Pathophysiology University of Athens,
P2: Reduction in interstudy variability of cardiac magnetic resonance imaging by identification of mitral valve plane and apex on long axis images.
S W M. Kirschbaum, RJM. van Geuns, T. Baks, JP. Aben, F.
Cademartiri, PJ. de Feyter. Erasmus medical center, Rotterdam P3: Cardiac MRI in Constrictive Pericarditis: Diagnostic Characteristics and Identification of Aetiology
Ronan J Curtin MD, Srikanth Sola MD, Michael K Banbury MD, Eugene H Blackstone MD, Allan L Klein MD. Cleveland Clinic Foundation, USA
P4: Comparison of SSFP and IR GRE techniques for measurement of total myocardial mass – influence of applied contrast dosage and implication for relative infarct size assessment.
Grothues Fa, Boenigk Ha, Ghanem Aa, Schwerdtfeger Aa, Bartels Da, Alpers Sa, Tempelmann Cb, Klein Hua. Department of Cardiology, Otto-von-Guericke-University, and Department of Neurology II, Otto-von-Guericke-University,
P5: Heart rate variability influences the image quality of coronary MRA in patients with normal sinus rhythm.
Tarinee Tangcharoen, M.D., Cosima Jahnke, M.D., Uwe Koehler, Ph.D., Bernhard Schnackenburg, Ph.D., Christoph Klein, M.D., Eckart Fleck, M.D., Eike Nagel, M.D. Department of Internal Medicine/Cardiology, German Heart Institute, Berlin, Germany
P6: Systematic analysis of cardiac morphology and function in patients with Brugada syndrome: magnetic resonance imaging findings. O. Catalano, S. Antonaci, M. Mussida, G. Moro, F. Cobelli, E. Ronchetti, R. Bloise, C. Napolitano, S. Priori. IRCCS Fondazione Salvatore Maugeri, Pavia, Italy P7: First Application of Myocardial T1 Mapping for the Assessment of Cardiac Amyloidosis.
Daniel R Messroghli, Ralf Wassmuth, Mirko Froehlich,
Andreas Greiser, Rainer Dietz, and Jeanette Schulz-Menger
P8: Diagnosis and Quantification of Atrial and Ventricular Septal Defects by Contrast-Enhanced Magnetic Resonance Imaging.
Bernhardt P, Levenson B, Renner P, Strohm O. Cardiac MRI at the
Hospital Agatharied, Hausham, Germany; Cardiac praxis, Berlin, Germany; MRI-Center at the St.-Gertrauden-Hospital, Berlin, Germany
16:00 - 16-40 Poster Session I / II Chair: Igor Klem (Stuttgart, Germany) 16:00 -16:05 P9: Embolic risk factors in atrial fibrillation determined by cardiac magnetic resonance in comparison to transesophageal echocardiography.
Bernhardt P, Pilz G, Klos M, Bräuner G, Höfling B. Cardiac MRI at the
P10: Atrio-ventricular function and interaction in patients after Fontan operation: a magnetic resonance study.
Klimes K , Ovrutski S., Abdul-Khaliq H., Hui W., Spors , Alexi-
Meskishvili , Felix R. Department of congenital heart defects and
Paediatric Cardiology, Deutsches Herzzentrum Berlin, Department of
Radiology and Nuclear Medicine, Charité Campus Virchow-Klinikum , Department of Thoracic and Cardiovascular Surgery, Deutsches Herzzentrum Berlin
16:10 -16:15 P11: Presentation, Patterns of Myocardial Damage and Clinical Course of Viral Myocarditis.
Heiko Mahrholdt, Anja Wagner, Claudia C. Deluigi, Eva M.
Kispert, Stefan Hager, Gabriel Meinhardt, Holger Vogelsberg,
Reinhard Kandolf and Udo Sechtem. Division of Cardiology,
Robert-Bosch-Medical Center, Stuttgart, Germany
16:15 -16:20 P12: A New Technique for Assessing Myocardial Ischemia using the BOLD Effect.
Jordin D. Green, Ph.D., Andreas Kumar, MD, Matthias G.
Friedrich, MD. Siemens Medical Solutions, Calgary, AB, Canada;
University of Calgary, Calgary, AB, Canada
P13: CMR-derived LVOT-quantification allows reliable differentiation without need for provocation in HCM.
Jeanette Schulz-Menger, Ralf Wassmuth, Hassan Abdel-Aty,
Daniel Messroghli, Matthias G Friedrich, Rainer Dietz
Franz-Volhard-Klinik, Charité Campus Buch, Universitätsmedizin
Berlin, Helios-Kliniken, Berlin, Germany; Stephenson CMR
Centre, Department of Cardiac Sciences, University of Calgary,
P14: Contrast enhanced CMR does not show a specific pattern of delayed contrast enhancement in patients with severe aortic stenosis.
Gabriel Meinhardt, Marcus Honold, Holger Vogelsberg,
Claudia C. Deluigi, Christine Goedecke, Heiko Mahrholdt and
Udo Sechtem. Robert Bosch Med. Ctr., Stuttgart, Germany
P15: Biplanar Measurements of Left Atrial Area and Volume Show High Reproducibility and Good Correlation to 3D Volumetry.
Mirko Fröhlich, Christoph Tillmanns, Lorenzo Monti, Daniel
Messroghli, Ralf Waßmuth, Rainer Dietz, Jeanette Schulz-Menger
Franz-Volhard-Klinik, Charité Campus Buch, Universitätsmedizin
Berlin, Helios-Kliniken, Berlin, Germany
P16: Intra-Abdominal Fat is a Strong Predictor of Vascular Hyperemic Responsiveness of the Superficial Femoral Artery. Juerg Schwitter, MD, Markus Oelhafen, PhD, Barbara M. Wyss, MD, Beatrice Amann-Vesti, MD, Thomas F. Lüscher, MD, Peter Boesiger, PhD University Hospital Zurich, Clinic of Cardiology and Cardio Vascular Center, University of Zurich and Swiss Federal Institute of Technology, Institute of Biomedical Engineering and Division of Angiology, University Hospital Zurich, Switzerland 16:00 - 16:40 Poster Session I / III Chair: Filipo Civaia (Monaco) 16:00 -16:05 P17: Comparison of MR coronary angiography before and after adenosine stress first pass perfusion.
Christoph Klein, Tarinee Tangcharoen, Bernhard Schnackenburg,
Cosima Jahnke, Eckart Fleck, Eike Nagel.
German Heart Institute Berlin, Berlin, Germany, Philips Medical Systems,
P18: Assessment of myocardial viability by the QRS Selvester Score. Comparison with Contrast-Enhanced Magnetic Resonance.
B. Belge, C. Brohet, A. Pasquet, J-L Vanoverschelde,
Gerber. Cliniques Universitaires Saint-Luc, Brussels, Belgium
P19: Planimetric and continuity equation assessment of aortic valve area by cardiac magnetic resonance. Comparison with transthoracic and transesophageal echocardiography.
AC. Pouleur, JB. Le Polain De Waroux, A. Pasquet, D. Vancraeynest,
JL. Vanoverschelde, B. Gerber. Cliniques Universitaires Saint-Luc, Brussels, Belgium.
P20: Reproducibility and accuracy of left ventricular mass measurement with real-time three-dimensional echocardiography: comparison with magnetic resonance imaging.
AC. Pouleur, JB. Le Polain De Waroux, A. Pasquet, B. Gerber, D.
Vancraeynest, P. Allain, O. Gerard, JL. Vanoverschelde Cliniques Universitaires Saint-Luc, Brussels, Belgium, Philips Medical System Research, Paris, France
P21: Equal accuracy of semi-automated 3D echocardiography estimates of left ventricular mass in patients with and without wall motion abnormalities: comparison with cardiac magnetic resonance.
J-B. Le Polain De Waroux, AC. Pouleur, D. Vancraeynest, A. Pasquet, B. Gerber, O. Gerard, P. Allain, JL. Vanoverschelde Cliniques Universitaires
Saint-Luc, Brussels, Belgium, Philips Medical System Research, Paris, France
P22: Myocardial edema is a feature of Tako-Tsubo cardiomyopathy and is related to the severity of global and regional systolic dysfunction.
Hassan Abdel-Aty, Myra Cocker, Abdullah Alsehly and Matthias G.
Friedrich. Stephenson CMR Centre at the Libin Cardiovascular Institute of Alberta, Departments of Cardiac Sciences and Radiology, University of Calgary, Canada
P23: Myocardial edema is a feature of hypertrophic cardiomyopathy and is related to the severity of hypertrophy.
Hassan Abdel-Aty, Myra Cocker, Abdullah Alsehly and Matthias G.
Friedrich. Stephenson CMR Centre at the Libin Cardiovascular Institute of Alberta, Departments of Cardiac Sciences and Radiology, University of Calgary, Canada
P24: Relation of tissue injury to left ventricular function in patients with acute myocarditis – A Cardiovascular MR study.
Myra Cocker, Hassan Abdel-Aty, and Matthias G. Friedrich. Stephenson
CMR Centre at the Libin Cardiovascular Institute of Alberta, Departments of Cardiac Sciences and Radiology, University of Calgary, Canada
16:45 - 18:20 SESSION IV CMP/Heart Failure/Myocarditis Chair: Bernhard Gerber (Brussels, Belgium) Dudley Penell (London, UK) 22: CMP 23: Heart Failure 24: Myocarditis 25: Case presentation 1
Jeanette Schulz-Menger (Berlin, Germany)
26: Case presentation 2 27: Case presentation 3
18:00 - 18:21 Oral abstract presentation 18:00 -18:07 28: Prediction of ventricular arrhythmias in patients with ischemic heart failure using delayed enhancement MRI. S. Sola, R. Setser, D. Sauri, M. Lieber , M. Desai, R. White Cleveland Clinic Foundation, USA 29: Late-enhancement in MRI associates with inflammatory changes in myocardial biopsies and serum in HCM. P. Sipola, M. Laakso, K. Peuhkurinen, V. Kärjä, K. Punnonen, J. Kuusisto. Kuopio University Hospital, Dept of Radiology, Medicine Pathology , and Clinical Chemistry, Finland 30: Systematic analysis of cardiac morphology and function in patients with Brugada syndrome: magnetic resonance imaging findings. O. Catalano, S. Antonaci, M. Mussida, G. Moro, F. Cobelli, E. Ronchetti , R. Bloise, C. Napolitano, S. Priori. IRCCS Fondazione Salvatore Maugeri, Pavia, Italy 18:21 - 19:00 SESSION V Results of Multicenter trials Chair: Albert van Rossum (Amsterdam, The Netherlands) Frank Rademakers (Leuven, The Netherlands) 18:20 -18:30 31: MR-Impact 32: MI Study 33: Mesa-trial 34: Iceland Study
Buses leaving at 19:15
Social Event at 19:30 – sponsored by GE Healthcare Kunsthistorisches Museum Wien (Kuppelsaal) Saturday May 20, 2006
08:30 - 10:05 SESSION VI Vascular, Congenital, Masses Chair: Guillem Pons-Llado (Barcelona, Spain) Heiko Marholdt (Stuttgart, Germany) 35: Vascular 36: Congenital diseases 37: Cardiac masses 38: Case Presentation 1 39: Case Presentation 2
Albert van Rossum (Amsterdam, The Netherlands)
40: Case Presentation 3
09:45 - 10:06 Oral Abstract Presentation 09:45 - 09:52 41: 3T CMR in patients after acute and chronic myocardial infarction: an initial experience.
R Nijveldt, A. Hirsch, AM Beek, MBM Hofman, AM Spijkerboer, JJ Piek,
AC van Rossum. VU University Medical Center, Amsterdam; Amsterdam Medical Center, Amsterdam; Netherlands
42: Microvascular obstruction detected by cardiovascular magnetic resonance in patients with first anterior AMI treated with primary PCI. Preliminary report.
D. Piotrowska, L. Kownacki, A. Cieszanowski, G. Opolski, L. Krolicki.
Department of Nuclear Medicine, Department of Cardiology, I and II Department of Radiology Medical University of Warsaw, Poland
43: Structural Changes of the Inferoseptal Left Ventricular Myocardium are associated with Mutations Causing Hypertrophic Cardiomyo-pathy: the Role of Cardiac Magnetic Resonance Imaging in Early Identification of HCM mutation carriers. T. Germans, AAM. Wilde, PA. Dijkmans, W. Chai, O. Kamp, YM. Pinto, AC.Van Rossum. VU University Medical Center, Amsterdam, Netherlands; Academic Medical Center, Amsterdam, Netherlands; ICIN, Utrecht, Netherlands; University Hospital Maastricht, Maastricht, Netherlands 10:06 - 11:00 Coffee Break and Poster Presentation II (10:15 – 10:55)
10:15 - 10:55 Poster Session II / I Chair: Heiko Marholdt (Stuttgart, Germany) 10:15 -10:20 P25: Wall motion abnormalities and fat infiltration assessed by MRI in patient with frequent premature ventricular complexes with LBBB morphology and inferior axis.
G.D. Aquaro, E.Strata, G. Di Bella, A. M. Sironi, D. De Marchi, M. Deiana, P. Keilberg, A. Pingitore, M.Institute of Clinical Physiology, CNR, Pisa, Italy
P26: Delayed enhancement evaluation of necrotic and perinecrotic tissue in patient with frequent premature ventricular complexes.
G.D.Aquaro, G.Di Bella, A.Pingitore, E.Strata, D.DeMarchi,D.Rovai, M.lombardi. Institute of Clinical Physiology, CNR, Pisa, Italy
P27: LV dysfunction in noncompaction cardiomyopathy patients: a global or regional problem?
K. Caliskan MD, RJ van Geuns MD PhD, AHHM Balk MD PhD.
Departments of Cardiology and Radiology,
P28: Relation between infarct size and left ventricular function in acute and chronic myocardial infarction.
D. Piotrowska, L. Kownacki, A. Cieszanowski, G. Opolski, L. Krolicki. Depatrment of Nuclear Medicine, Department of Cardiology, I and II Department of Radiology Medical University of Warsaw, Poland
P29: MR imaging of right ventricular dysfunction in patients with no clinical symptoms of ARVD.
D. Piotrowska, L. Kownacki, A. Cieszanowski, G. Opolski, L. Krolicki. Department of Nuclear Medicine, Department of Cardiology, I and II Department of Radiology Medical University of Warsaw, Poland
P30: Cardiac Complications Of Renal Disease (CCORD): CMR findings. Neil Filipchuk, Hassan Abdel-Aty, and Matthias G. Friedrich Stephenson CMR Centre at the Libin Cardiovascular Institute of Alberta, Departments of Cardiac Sciences and Radiology, University of Calgary, Canada P31: A Proposed standard for Cardiovascular Magnetic Resonance reporting.
DR Kaura, N Filipchuk, D Patton, A Al Sehly, H Abdel-Aty, A Kumar, MG Friedrich. Stevenson CMR Centre, University of Calgary, Canada
P32: Rapid analysis of left ventricular function in patients following acute myocardial infarction using cine CMR. R Nijveldt, AM Beek, RJ van der Geest, MBM Hofman, AC van Rossum. VU University Medical Center, Amsterdam; Leiden University Medical Center, Leiden; The Netherlands
10:15 - 10:55 Poster Session II / II Chair: Jeanette Schulz-Menger (Berlin, Germany) 10:15 -10:20 P33: Right ventricular fractional shortening is a more reliable measure for right ventricular function than TAPSE.
R Nijveldt, T Germans, GP McCann, AM Beek, AC van Rossum. VU University Medical Center, Amsterdam, the Netherlands; University Hospitals Leicester, United Kingdom
P34: Measurement of age related effects on left atrial volume and function: assessment with cardiac magnetic resonance imaging
Tjeerd Germans, Marco J.W. Götte, Robin Nijveldt, Aernout M. Beek, Jean G.F. Bronzwaer, Walter A. Paulus, Albert C. van Rossum . VU University Medical Center, Amsterdam, the Netherlands
P35: Assessment of regional myocardial strain using strain- encoded MRI (SENC) in patients with unimpaired left ventricular function.
Thomas Thouet, Sebastian Kelle, Ahmed Fahmy, Ingo Paetsch, Nael Osman, Eike Nagel. Internal medicine/Cardiology; German Heart Institute Berlin; Dept. Radiology, Johns Hopkins Baltimore, USA
P36: Impact of exercise capacity on myocardial high-energy phosphate metabolism: A 31-Phosphorous magnetic resonance spectroscopy study.
Klug G, Zwick RH, Wolf C, Schocke MF, Frick M, Jaschke W, Pachinger O, Metzler B. Clinical Division of Cardiology, Innsbruck Medical University Radiology Department, Innsbruck Medical University, Austria
P37: Delayed enhancement in DCM is unrelated to virus persistence or the presence of inflammation in myocardial biopsies.
Jörg Ruppert, Sönke Langner, Alexander Staudt, Andreas Streitbörger, Norbert Hosten, Stefan Felix Departments of Cardiology and Radiology, Ernst-Moritz-Arndt-University, Greifswald, Germany
P38: Perfusion of the left ventricular myocardium as revealed by 3T MRI.
Anders Hervold, Stig F. Samnøy, Birgit Schulz and Terje H. Larsen. Haukeland University Hospital; Departments of Cardiology, Clinical engineering and Radiology, Norway
P39: 3D Vector Visualization of Ventricular Wall Motion across a volume by the use of 3T MRI.
Stig F. Samnøy, Anders Hervold, Gottfried Greve, Terje H. Larsen.
Haukeland University Hospital, Depts. of Clinical Engineering, Cardiology, Radiology. Bergen University College, Norway
P40: Cardiac function analysis with MRI: Assessment of measurement accuracy in a prospective multicenter study.
Claudia Fröhlich, Katrin Klimes, Peter Barth , Andrea Kelter-Klöpping ,
Julia Krüger, Felix Berger, Roland Felix, Hans Meyer, Philipp Beerbaum,Titus Kuehne, Matthias Gutberlet, Humboldt University Berlin, Charité, Department of Radiology, Deutsches Herzzentrum Berlin, Department of Congenital Heart Diseases and Pediatric Cardiology, Deutsches Herz und Diabeteszentrum Bad Oeynhausen, Department of Pediatric Cardiology, Germany
10:15 - 10:55 Poster Session II / III Chair: Sanjay Prasad (London, UK) P41: Cardiac MRI for the Assessment of Risk of Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy. L. Toth, R. Faludi, E. Fodi, M. Knausz, A. Varga-Szemes, I. Repa, L. Papp, T. Simor. University of Pecs Heart Institute, Pecs, Hungary P42: Safety and complications of Adenosine-Stress-CMR in the evaluation of coronary artery disease. D. Hardung, H. Omran, K. Miszalski-Jamka, J. Schnapauff, B. Saxler, G. von der Recke. St.-Marien-Hospital Bonn-Venusberg, Bonn, Germany P43: The dark rim artifact in first pass myocardial perfusion: Influence of spatial and temporal resolution.
Nidal Al-Saadi, Geir Torheim, H. Glenn Reynolds, Daniele De Marchi, Silvia Burchielli, Massimo Lombardi. Institute of Cardiac MRT, Berlin, Germany; GE Healthcare AS, Oslo, Norway; GE Healthcare, Boston, USA; MRI Laboratory, C.N.R., Pisa, Italy
P44: Is standard echocardiography really sufficient for diagnosing previously unknown chronic myocardial infarction? A comparison to cardiac magnetic resonance.
Giso von der Recke, MD, Heyder Omran, MD, Karol Miszalski-
Jamka, MD, Christoph Hammerstingel, MD, Bernd Saxler, Jan
Schnapauff, David Hardung, MD. St.-Marien-Hospital, Bonn, Germany
P45: Regional myocardial perfusion mapping of CMR images in comparison to SPECT.
J. Misko, A. Teresinska, E. Skrobowska, C. Kepka, L. Chojnowska, K.
Kukula, M. Dabrowski, M. Skwarek, A. Warczynska, W. Ruzyllo. Miedzyleski Specialistic Hospital, Institute of Cardiology, Medical Military Institute,Warsaw, Poland
P46: Imaging Cardiac Amyloid with CMR
Bryant T, Peebles CR, Harden SP. Department of Cardiothoracic Radiology, Southampton General Hospital, Southampton, UK
P47: Manual Contouring vs. contour detection for left ventricular time volume curve analysis to demonstrate diastolic dysfunction in patients with fabrys disease.
Juli CF, Peebles C, Widmer U, Froehlich J, Eckhardt BP. Cantonal Hospital Winterthur, Inst. for Clin. Radiology, MRI-Centre, Switzerland, Dept. of Medicine, Zurich University Hospital, Switzerland, Southampton University Hospital, Dept. Cardiothoracic Radiology, United Kingdom
P48: The Influence of the Introduction of the “Late Enhancement” Technique on the Indication for Cardiac Magnetic Resonance Imaging: Single-Centre Experience. Hafner T, Marko C, Gstaltner A, Strau G, Sellner Y, Böck R, Podczeck- Schweighofer A. 5th Department for Internal Medicine with Cardiology, Kaiser-Franz-Josef-Spital, Vienna, Austria 11:00 - 12:36 SESSION VII CONTRAST AGENTS in CVMR Chair: Matthias Friedrich (Calgary, Canada) Igor Klem (Stuttgart, Germany) 11:00 -11:15 44: Blood pool contrast agents in CVMR 45: Use of CA in viability imaging 46: Mapping of Myocardial Metabolism in Ischemic Hearts using Hyperpolarized 13C-puruvate Magnetic Resonance Imaging 47: Case presentation 1 48: Case presentation 2
12:15 - 12:36 Oral abstract presentation 12:15 -12:22 49: Evidence of more severe left ventricular remodeling in hemodialysis as compared with peritoneal dialysis. Insights from CMR. Neil Filipchuk, Hassan Abdel-Aty, and Matthias G. Friedrich Stephenson CMR Centre at the Libin Cardiovascular Institute of Alberta, Departments of Cardiac Sciences and Radiology, University of Calgary, Canada 50: Detection of chronic myocardial infarction in patients undergoing MR coronary artery imaging using the intravascular CA MS-325.
Thouet T, Kelle S, Schnackenburg B, Kokocinski T, Fleck E, Nagel E. Internal Medicin/Cardiology; German Heart Institute Berlin, Germany
51: Differences of Rosuvastatin and Simvastatin on Myocardial High- Energy Phosphate Metabolism: A 31-Phosphorous Magnetic Resonance Spectroscopy Study.
Klug G, Frick M, Wolf C, Zwick RH, Schocke MF, Lechleitner M, Jaschke
W, Pachinger O, Metzler B. Clinical Division of Cardiology, Innsbruck Medical University; Radiology Department, Innsbruck Medical University; Clinical Division of General Internal Medicine, Innsbruck Medical University, Austria
12:36 - 14:00 Lunch (Klimt Room)
14:00 - 15:15 SESSION VIII INDUSTRY FORUM Chair: Peter Buser (Basel, Switzerland) Herbert Frank (Tulln, Austria) 14:00 -14:15 52: Bracco 53: Siemens 54: Schering
Hanns-Joachim Weinmann (Berlin, Germany)
55: GE Healthcare
Patrice Hervo, MR Advanced Application Europe (Buc, France)
56: Philips
15:15 - 16:00 Coffee break
16:00 - 17:15 SESSION IX Chair: Jeanette Schulz Menger (Berlin, Germany) Philip Kilner (London, UK) 16:00 -16:15 57: Interventional MRI 58: Hyperpolerized Contrast Media – Malmö 9 59: Plaque imaging 60: Do we need 3 T imaging
Sebastian Globits (St. Pölten, Austria)
61: The future of CVMR in Europe
17:15 - 19:00 SESSIONX
The CMR Exam will be a written exam consisting of two parts.
One part is a multiple choice test, one part case studies.
RESUMEN-COMENTARIO DE LA CUESTIÓN 94 A Tomás de Aquino se le conoce como al autor de una síntesis entre aristotelismo y cristianismo. Bien, una síntesis no es lo mismo que una coincidencia plena: ambas éticas tienen carácter teleólogico (toda la argumentación se construye sobre el fin del ser humano), ambas son éticas materiales, ambas sitúan a la felicidad como el fin suprem
The AccuSign ® MET test uses solid-phase immunoassay technol- ogy for the qualitative detection of methamphetamine in humanurine. The test is based on the principle of the highly specificimmunochemical reactions between antigens and antibodies whichare used for the analysis of specific substances in biological fluids. The test relies on the competition between the drug conjugates andthe drug